Background MRSA developed as a result of antibiotic overuse/ misuse in humans and has garnered significant attention since it was first discovered in 1960. 2 For a long time, MRSA remained relatively confined to hospitals and chronic-care facilities such as nursing homes. Aggressive infection-control procedures have slowed the spread of MRSA, but only minimally. In recent years, MRSA has found its way into communities outside the confines of hospitals where it was normally found. The MRSA found in the community (also known as community-acquired MRSA) has distinct microbiologic differences, most notably its susceptibility pattern to antibiotics. Whereas hospital-acquired MRSA is often resistant to multiple classes of antibiotics, the community-acquired version often lacks such wideranging resistance. Community-acquired MRSA also has a tendency to be a more aggressive infectious agent than its nonresistant counterparts.
Treatment Options
Community-acquired MRSA is still a causative agent that most physicians in the community do not think about and is rarely susceptible to the antibiotics typically used as first-line therapies for skin and soft-tissue infections. The oral antibiotics that athletic trainers are likely to see their athletes taking include cephalexin, amoxicillin, and amoxicillin/clavulanate. These are appropriate antibiotics for a physician to choose as treatment for a basic soft-tissue infection. An indication that an infection might be MRSA is when the infection does not respond appropriately to the antibiotics administered. If this is the case, sending the athlete back to the physician for reevaluation is warranted. If MRSA is suspected in an athlete, either by antibiotic failure or skin infection in a teammate of a confirmed MRSA case, the treating physician needs to be made aware of the potential problem.
Control Measures
The risk factors that have been identified with MRSA outbreaks in the community and athletes are item sharing, close physical contact, open wounds, and poor hygiene. Once a MRSA skin infection has been confirmed in an athlete, there are several control measures to consider to prevent its spread. Proper hand washing and showering and using antibacterial soap are useful. Keeping cuts and abrasions well cleaned and covered is a must. Avoid sharing equipment. If equipment sharing is unavoidable, cleaning the equipment after each use is the next best option. The athletic trainer should counsel athletes to avoid sharing items such as razors. If more than one case of MRSA is confirmed, treatment of the entire team (to possibly include the coaching and medical staff, as well) with intranasal topical antibiotics might be necessary. In consultation with the team physician, contacting the local health department might be a prudent action if you have several cases of MRSA.
Several of the antibiotics that should be effective in MRSA skin infections should be used with caution. An athletic trainer who sees an athlete with known or suspected MRSA on these antibiotics needs to be vigilant in monitoring for signs of ineffective antibiotics. The classes of antibiotics of concern include quinolones, macrolides, and sulfonamides, as well as clindamycin, which might have cross-resistance (which is resistance to those classes of antibiotics in addition to the methicillin). Rifampin is often effective, but only in combination with other antibiotics. Culturing skin infections, especially if there are exudates (pus) pres-
